報告順序 |
投稿者 |
題目 |
|---|---|---|
OA-01 |
江蘇峰 |
Deciphering the regulatory mechanism of the signal-dependent gene expression via an integrative computational approach |
OA-02 |
蕭丞凱 |
Association between enhancer and alternative splicing |
OA-03 |
黃允辰 |
A novel underlying mechanism causing enzalutamide resistance in prostate cancer. |
OA-04 |
鍾馨瑤 |
A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence |
OA-05 |
汪雅雲 |
TBC1D21 is vital to maintain the integrity of mitochondria sheath and flagellum in murine sperm |
OA-06 |
陳胤丞 |
Three Different Amplicon Unveils the Changes of Fungal Community through Tea Fermentation Process |
OB-01 |
李嘉欣 |
The development of high throughput kinase activity platform using nanoLC-MS/MS with DIA approach |
OB-02 |
林詩語 |
Development of an automated immuno-MALDI mass spectrometry assay for detection of interstitial collagenase in dried saliva spot sample. |
OB-03 |
郭承儒 |
A multi-omic analysis reveals the role of fumarate in regulating the virulence of Enterohemorrhagic Escherichia coli |
OB-04 |
李永國 |
Glycomics Investigation of Colon Cancer-Initiating Cells |
OB-05 |
蕭鼎峰 |
Screening and Verification of the potential serum biomarkers for prediction of EGFR-TKI treatment in lung adenocarcinoma by MRM-based quantitative proteomics approach |
OB-06 |
張海妍 |
Quantitative Proteomics and Phosphoproteomics Analyses Reveal the Regulatory Roles of ZNF322A in lung cancer |
OC-01 |
王庭 |
Combination Therapy with Dendritic Cell Vaccine and PD-L1 Immune Checkpoint Inhibitor for Hepatocellular Carcinoma in An Orthotopic Mouse Model |
OC-02 |
翁靖傑 |
Loss of the Transcriptional Repressor TGIF1 Results in Enhanced Kras-Driven Development of Pancreatic Cancer |
OC-03 |
石一㚬 |
A Turn-on Fluorescence Sensor for Heparin Detection Based on a Release of Taiwan Cobra Cardiotoxin from a DNA Aptamer or Adenosine-Based Molecular Beacon |
OC-04 |
鄭以安 |
Non-covalent modification of mPEGylated nanoparticles by humanized bispecific antibodies for selective therapy |
OC-05 |
王亮鈞 |
VINCRISTINE INDUCES APOPTOSIS OF HUMAN LEUKEMIA U937 CELLS VIA SIRT3/ROS/p38 MAPK/TTP AXIS-MEDIATED TNF-α UPREGULATION |
OC-06 |
呂韻綺 |
Specific activation of a pro-Remicade can enhance the selectivity and safety of rheumatoid arthritis therapy |
No.
|
投稿者 |
題目 |
|---|---|---|
A1-01 |
陳庭萱 |
Construction of an IRES data knowledge base for understanding the regulation of translation initiation in human |
A1-02 |
楊宗曉 |
Cis-regulatory module identification by transcription factor binding site distribution and corresponding epigenetic profiles |
A1-03 |
hsihchia.hsieh & pei-gin hsieh |
Precision Therapy and Density: Animals - nonstandard unique function |
A1-04 |
傅曉婷 |
Development of a computational variant scoring system for pathogenicity assessments of clinical exome sequencing |
A1-05 |
黃佳欣 |
A bioinformatics-based exploration of the promoter occupancy and alternative splicing pattern in the human genome |
A1-06 |
張凱禮 |
Analysis of common targets for circular RNAs |
A1-07 |
陳奇君 |
SeqCP: a sequence-based algorithm for searching circularly permuted proteins |
A1-08 |
劉丞哲 |
Identification and prediction of fungal core genes |
A1-09 |
陳盈帆 |
Targets identification and translatome profiling of hnRMPM targeting transcripts in hypoxic condition |
A1-10 |
朱韻如 |
Metagenomic analysis reveals microbiota shifting in polluted sediment of Kaohsiung Port |
A2-01 |
李杰臨 |
A Genomic Wide Association Study of hyperuricemia and hypertension using Taiwan Biobank |
A2-02 |
朱俊憲 |
Non-oncogenic functions of human TIAM2S revealed by a whole-transcriptome and enrichment analysis |
A2-03 |
Liya Paramita |
Artificial intelligence pipeline to predict successful rates of In Vitro Fertilization (IVF) outcomes |
A2-04 |
盧配天 |
Fetal Fraction Estimation Based on Single-Nucleotide Polymophism from Cell-Free DNA |
A2-05 |
林靖茹 |
Systematic Identification of Pathogenic Splicing Mutations of TSC1/2 |
A2-06 |
林信男 |
MapCaller – An integrated and efficient tool for short-read mapping and variant calling using high-throughput sequenced data |
A2-07 |
林逸宣 |
Identification of FGF9 IRES-mediated translational initiation complex under Hypoxia |
A2-08 |
蔡宜修 |
Donor Human Milk Microbiota and the Survey of Donors’ Health Status from Human Milk Bank in Southern Taiwan |
A2-09 |
蔡亞娟 |
In silicon identification of microRNAs and their target genes in the pathogenesis of endometriosis |
A2-10 |
李偉豪 |
Characterizing the Cancer-Associated Microbiome with Small RNA Sequencing Data |
A2-11 |
薛阿成 |
Idefication of inhibitors to block hypoxia-induced FGF9 IRES activity using digital and biological screenings |
A2-12 |
劉玉凡 |
Development of Tumour Neo-antigens targeted cytotoxic T-cell derived from missense Somatic Mutations as Cancer Vaccines in Oral Squamous Cell Carcinoma |
A2-13 |
林慧宣 |
Exploration of the coding potential of circular RNAs |
A2-14 |
張培均 |
Drug Targets Discovery of Atherosclerosis Based on Synthetic Pathogenicity Genes |
A2-15 |
余亞珊 |
Genotoxic Stress-Induced Phosphorylated DHX9 Promotes Oncogenic CircRNA Expression and Development of Chemoresistance |
A2-16 |
陳品萱 |
Detection of genetic aberrations through whole exome sequencing data analysis in children with global developmental delay/ intellectual disability |
A2-17 |
王允麟 |
Systematic Analysis of the Effect of UTR Variants on RNA Stability |
A2-18 |
江宏倫 |
ABERRANT EXON SKIPPING OF CAMTA2 IS INDUCED BY BRANCHPOINT SNP |
A2-19 |
李幃平 |
Systemic Analysis of the Effects of Disease-associated Variants in UTRs on Translational Efficiency of mRNAs |
A2-20 |
張毓琪 |
Translation Efficiency is Affected by Disease-Associated SNPs in Untranslated Region |
A2-21 |
汪雅雲 |
SEPT14 Mutations and Teratozoospermia: Genetic Effects on Sperm Head Morphology and DNA Integrity |
A2-22 |
鄭欣怡 |
Identification of LATS1/2 in sustaining cardiomyocytes differentiated from human embryonic stem cells. |
A2-23 |
林進之 |
Many human RNA viruses show extraordinarily stringent selective constraints on protein evolution |
A2-24 |
馬瀰嘉 |
USING METAGENOMICS TO PREDICT PREGNANCY OR NOT FOR IN VITRO FERTILIZATION PATIENTS |
A2-25 |
閻欣怡 |
Dicer-mediated chemoresistance in colorectal cancer |
A2-26 |
楊翔傑 |
A Diverse Role of Aurora-A Kinase in Tumor Progression Depends on Lymphocyte Infiltration in Tumor Microenvironment |
A2-27 |
王靖媛 |
Development and validation of target-sequencing panel for skeletal dysplasia |
A2-28 |
黃偉倫 |
Identification of the potential mechanisms for anti-cancer drug induced STAT3 activation in cancer drug-resistance by gene expression profile analysis |
A2-29 |
林忠信 |
FOXA1 transcriptionally up-regulates cyclinB1 expression to enhance chondrosarcoma progression |
A3-01 |
周緻雅 |
PlantPAN3.0: an upgraded resource for protein structure-based features and genome-wide map of regulatory factors in plants |
A3-02 |
曾冠傑 |
EXPath 2.0: an update database for revealing critical plant metabolic pathways from high-throughput gene expression data |
A3-03 |
林竹君 |
Does sod culture improve the soil microbiome? A case of the pomelo orchards in Taiwan. |
A3-04 |
林雅琪 |
Transcriptomic profiling of virus-induced hypersensitive response in C. quinoa leaves |
A3-05 |
唐中道 |
Analysis of bacterial composition of sponge in seawater aquafarm reveals the influence of environment in microbiota in sponge |
林俐均 |
Targeting Glutaminase Overcomes Oxaliplatin Resistance in Colorectal Cancer | |
B1-02 |
陳琮明 |
Metabolomics of Hyalella Azteca for the ecological assessment of polluted sediments in Kaohsiung Port |
B1-03 |
李貫綸 |
PM2.5 induced cardiac hypertrophy via CREB/GSK3b/SOS1 pathway and metabolomics alterations |
B1-04 |
Ming-Lung Ho |
Potential general biomarkers for common malignancies-galns and paep |
B1-05 |
施佩君 |
Plasticizer induced tumor migration through downregulation of sialyltransferase expression in human colon cancer cells |
B1-06 |
林宗憲 |
Characterization and verification of serum n-glycome in oral cancer patients |
B1-07 |
徐嘉偉 |
Integrated analyses of metabolomics and transcriptomics reveal perturbation of polyamine pathway in oral cavity squamous cell carcinoma |
B1-08 |
陳盈嵐 |
Identification of arabidopsis protease for maturation of pr-1 derived signaling peptide to active sar |
B1-09 |
Kai-Ting Fan |
Application of data-independent acquisition approach to study the proteome change from early to later phases of tomato pathogenesis responses |
B1-10 |
Cheng, Yu-Hsuan |
Method Development for Monitoring of Immunoglobulin Isotypes and IgM Glycosylation for Patients with IgA Nephropathy by Using Liquid Chromatography-Tandem Mass Spectrometry |
B1-11 |
Brahmadhi A |
Application of Liquid Chromatography-Mass Spectrometry Analytical Methods to Exosomal Proteomics Study |
B1-12 |
王品璿 |
Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry |
B1-13 |
何玟穎 |
Identification and screen of biomarker of Di-(2-prophylheptyl) phthalate (DPHP) exposure using a high resolution mass spectrometry-based metabolomics strategy |
B1-14 |
陳允杰 |
Discovery of chemical markers in spoiled eggs using mass spectrometry-based untargeted metabolomics |
B1-15 |
陳恒志 |
Developing a general procedure for identifying metabolites of new psychoactive substances employing mass spectrometry-based untargeted metabolomics using 4-MeO-α-PVP as an example to demonstrate proof-of-concept |
B1-16 |
葉芸 |
Discovery of freshness markers in fish using mass spectrometry-based untargeted metabolomics |
B2-01 |
陳儀瑾 |
Antibodyome Analysis of Attention-Deficit/Hyperactivity Disorder using Escherichia Coli Proteome Chips |
B2-02 |
劉若娟 |
Comparison of Urine Protein Profiles between Ketamine Cystitis Patients and Health Controls by iTRAQ-based by Quantitative Proteomics Analysis |
B2-03 |
林育存 |
Discovery and verification of phosphoprotein signature for predicting prognosis of patients with hepatocellular carcinoma |
B2-04 |
Samuel herianto |
Yeast proteome microarrays based systematic analysis of Phosphatidylinositol-5-phosphate-(PI5P)-binding protein interactome |
B2-05 |
涂瑋儒 |
Developing the mass spectrometry-based multi-omics technologies for exploring the energy metabolism pathways of renal cancer and clinical applications |
B2-06 |
蔡佳蓉 |
Proteomics investigation of lesion-dependent salivary proteins for OSCC monitoring |
B2-07 |
蕭永晉 |
Assessment of candidate biomarkers in paired saliva and plasma samples from oral cancer patients by targeted mass spectrometry |
B2-08 |
劉昱暄 |
Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry. |
B2-09 |
徐竹君 |
Antibodyome analysis of schizophrenia using Escherichia Coli Proteome Chips |
B2-10 |
吳嘉群 |
Discovery of Salivary Biomarkers for Oral Cancer by Lectin Affinity Capture Coupled with iTRAQ-Based Quantitative Glycoproteomics Approach |
B2-11 |
呂昱葶 |
Development of Lectin-Based Glycopeptide-Enrichment Approach Coupled with MRM Assay for Verifying Oral Cancer Candidate Glycobiomarkers |
B2-12 |
陳鈺儒 |
Evaluating the toxicity of zebrafish embryo to spermidine carbon quantum dots by proteomics analysis |
B2-13 |
陳亭瑜 |
Structural changes in Golgi-endoplasmic reticulum system mark differentiation of SH-SY5Y neuroblastoma cells according to cell architecture-based protein interactomics |
B2-14 |
戴正倫 |
Identification of protein interaction changes marking the cisplatin cytotoxicity to bladder cancer cells |
B2-15 |
劉孟筑 |
The Investigation of High Intensity Interval Training on Left Ventricular Fibrosis in Cardiac Patients by Proteomics |
B2-16 |
張鈺 |
Detection of PSMB9 protein in clinical samples for renal cell carcinoma biomarker verification |
B2-17 |
謝巧慧 |
Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM to Suppress Neuroblastoma Progression |
B2-18 |
蔡東翰 |
Subcellular proteomics help identify changes in protein interactions in response to EV71 infection |
B2-19 |
吳欣怡 |
Assessing the Similarity between Random Copolymer Drug Glatiramer Acetate by using LC-MS Data Coupling with Hypothesis Testing |
B2-20 |
劉玉晴 |
Protein Biomarker Discovery for Methicillin-sensitive, heterogeneous Vancomycin-Intermediate and Vancomycin-Intermediate Staphylococcus aureus Strains by Label-Free DIA Quantitative Proteomics |
B2-21 |
簡昆鎰 |
Enrichment of sub-peptidome for in-depth proteome analysis |
B2-22 |
柯品妤 |
Proteomic analysis reveals the anticancer mechanism of novel cationic anticancer peptides on human gastric cancer cell line AGS |
B2-23 |
杜傑騰 |
Qualification and Quantitation of Intact Proteins Using Low-Resolution MS with CID and ETD Techniques |
B2-24 |
郭政佑 |
Proteomic analysis of rat kidney under maleic acid treatment by SWATH-MS technology |
B2-25 |
賴銘志 |
Integrated omics profiling identifies hypoxia-regulated genes in hct116 colon cancer cells |
B2-26 |
YCF |
Application of the data-independent acquisition (dia) approach on the study of the proteomics in different stagges of cell cycle |
B2-27 |
Wei-Hsuan-Yang |
SAA Variant Pattern Analysis by Nanoprobe-based Mass Spectrometry for Detection of Cancers of the Digestive System |
B2-28 |
吳芝儀 |
Phthalate exposure enhances drug resistance in colon cancer through AKT/GSK-3β/β-catenin pathway mediated up-regulation of SLFN5 |
B3-01 |
陳彥劦 |
Applications of database integration for identifying glycogenes and neural network for revealing unique signatures in pan-cancer analysis |
B3-02 |
黃建豪 |
Profiling genome wide DNA methylation and transcription in Coprinus cinereus and Schizophyllum commune |
B3-03 |
Yi-Ju-Chen |
Proteogenomics landscape of early lung adenocarcinoma patients identifies stratification hallmarks of early onset and progression |
黃信凱 |
Investigation of influence of microbiota on colorectal cancer patients using Irinotecan (CPT-11) induced diarrhea | |
C2-01 |
吳怡萱 |
Development of the protease-activated pro-Humira to prevent the interfere effect of neutralizing anti-idiotype antibody |
C2-02 |
李子瑜 |
Development of pro-immune checkpoint antibody to increase selectivity and reduce side effects |
C2-03 |
※吳亭儀 |
Non-covalent Modified mPEGylated Nanodrugs with Anti-PEG Bispecific Antibody(αmPEGxαCD20) to Enhance Tumor Specific Targeting and Therapeutic Efficacy in Lymphoma |
C2-04 |
黃怡嘉 |
To compare the immunogenicity of pro-antibody that mask antibody-binding sites with hinge domain or coiled-coil domain in mice model |
C4-01 |
劉建均 |
Screening of DNA aptamers toward oral cancer biomarkers using plate-based SELEX and next-generation sequencing |
C4-02 |
葉宏淳 |
Butanolide compounds from Cinnamomum kotoense induce melanoma autophagy and apoptosis via MAPK pathway in vivo and in vitro |
C4-03 |
詹雅玲 |
Human T-cell lymphoma invasion and metastasis 2 promotes chronic inflammation mediated tumorigenicity |
C4-04 |
傅曉婷 |
The survival time of non-small cell lung cancer patients conducted with different treatments, alone or in combination: A single center study. |
C4-05 |
林宜玫 |
The relationship of serotonin receptor 1A polymorphisms with woman menopause symptom and pro-inflammatory cytokines |
C4-06 |
張培均 |
Inhibition Assessment of Anticancer Drugs for ALK Gene Variation Target |
C4-07 |
※王怡絜 |
O-Methyleugenol from Cinnamomum subavenium Enhance Doxorubicin Chemotherapy Efficacy to Inhibit Human Lung Cancer Cell Proliferation and Reverse Epithelial-to-Mesenchymal Transition Pathway |
C4-08 |
吳秉璁 |
Development of a humanized bi-specific antibody (αEphA2×α-mPEG) for specific targeting and endocytosis of glycosidic switch liposomes to EphA2-expressing metastatic tumors |
C4-09 |
※黃佳慧 |
ARSENIC TRIOXIDE INDUCES APOPTOSIS IN BCR-ABL1-POSITIVE LEUKEMIA CELLS VIA P38 MAPK-AND AKT-MEDIATED MCL1 DOWNREGULATION |
C4-10 |
李苑親 |
EGFR-Mediated AGO2 Phosphorylation Upregulates MCL1 Expression in ABT-263-treated Human Leukemia Cells |
C4-11 |
邱靖婷 |
AUTOPHAGIC DEGRADATION OF HUR ELICITS DOWNREGULATION OF SURVIVIN AND MCL1 IN YM-155-TREATED HUMAN LEUKEMIA K562 CELLS |
C4-12 |
黃奕中 |
Tet-on the expression of ERCC1 increase radioresistance of colorectal cancer in vivo |
C4-13 |
萬郁瑩 |
Extract Capsicum annuum chemical composition and enhance chemodrug inhibition lung cancer growth |
C4-14 |
謝雅茹 |
The Roles of GSKIP in Metastatic Ability and Radioresistance of Oral Squamous Cell Carcinoma |
C4-15 |
黃柏誠 |
Development of protease-activated pro-antibody by structure-based computational methods |
C4-16 |
陳慧蓁 |
An autologous hinge as universal antibody lock enhances selectivity of antibody whilst prevent the binding of anti-idiotype antibody |
C4-17 |
李安倫 |
The microRNA classifiers as ancillary diagnosis biomarkers for urothelial carcinoma of chronic kidney disease |
C4-18 |
吳佩珊 |
Development of protease-activated pro-anti-CTLA4 antibody to enhance disease selectivity and reduce the side effects |
C4-19 |
李承恩 |
To investigate the importance of disulfide bond to spatial-hindrance-based pro-antibody |
C4-20 |
李佳靜 |
One-step Mixing of Anti-mPEG Bispecific Antibody (mPEG×HER2) with PEGylated Nanoparticles to Enhance Its Therapeutic Efficacy in Ovarian Cancer |
C4-21 |
蔡婉琪 |
Compound X from Ardisia virens inhibits tumorigenesis and metastatic potential in pancreatic cancer |
C4-22 |
全鄧雅文 |
Effect of fucoidan from Fucus vesiculosus on lung adenocarcinoma cells resistance to chemotherapeutic drug doxorubicin |
C4-23 |
王碩鴻 |
To develop a protease inhibitor for Zika virus therapy |
C4-24 |
柯建志 |
Radiation-modulated prostate cancer derived-exosomes regulates the epithelial-mesenchymal transition of recipient cells |
C4-25 |
廖子毅 |
Bispecific antibody (CD20 Ab × mPEG scFv) specific targets liquid tumors to enhance anti-tumor efficacy by actively grab PEGylated liposomal doxorubicin |
C4-26 |
※趙郁舒 |
Leader compounds provide less cytotoxicity and higher specificity to inhibit type I~IV Dengue |
C4-27 |
※陳怡如 |
Developing Bispecific Antibody for Synergistic Anti-Cancer Effects by Precise Targeting and Accumulation of PEGylated Drugs |
C4-28 |
洪詩婷 |
Correlation of anti-PEG antibody with the therapeutic efficacy of Mircera |
C4-29 |
劉蕙如 |
Targeted mPEG-nanoparticle Release into Blood-Brain Barrier by a Protease Cleavable BsAb (mPEG×TfR) |